Erestz 245 mg FC tablets
PDF Leaflet Revision Date: 12 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
For the treatment of HIV-1 infection in adults with no prior antiretroviral treatment history.
Dosage (summary)
One tablet orally once daily with food for adults weighing at least 35 kg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- CYP3A inducers
- Proton pump inhibitors
- St. John's Wort
Contraindications
- Hypersensitivity to components
- Moderate to severe renal impairment
- Severe hepatic impairment
Common side effects
- Nausea
- Dizziness
- Fatigue
- Insomnia
- Diarrhoea
Counselling Points
- Take with food
- Monitor for liver function
- Adhere to therapy to prevent HIV transmission
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Pancreatitis
- Immune reactivation syndrome
Important Disclaimer
The Erestz 245 mg FC tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
